| Primary |
|
| White Blood Cell Count Increased |
50.0% |
| Drug Level Increased |
25.0% |
| Urinary Incontinence |
25.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
55.9% |
| Product Used For Unknown Indication |
14.9% |
| Schizophrenia |
6.2% |
| Petit Mal Epilepsy |
4.1% |
| Psychotic Disorder |
4.1% |
| Depression |
3.1% |
| Colon Cancer |
2.1% |
| Delusion |
1.5% |
| Restlessness |
1.5% |
| Mania |
1.0% |
| Prophylaxis |
1.0% |
| Respiratory Depression |
1.0% |
| Affect Lability |
0.5% |
| Chronic Obstructive Pulmonary Disease |
0.5% |
| Hyperlipidaemia |
0.5% |
| Hypertension |
0.5% |
| Nausea |
0.5% |
| Senile Osteoporosis |
0.5% |
| Tension |
0.5% |
|
| Suicide Attempt |
11.1% |
| Small Intestinal Perforation |
9.7% |
| Tachycardia |
9.7% |
| Neutropenia |
8.3% |
| Thrombophlebitis |
8.3% |
| Overdose |
6.9% |
| Pulmonary Embolism |
6.9% |
| Salivary Hypersecretion |
5.6% |
| Galactorrhoea |
4.2% |
| Psychomotor Skills Impaired |
4.2% |
| White Blood Cell Count Increased |
4.2% |
| Intentional Overdose |
2.8% |
| Pneumonia |
2.8% |
| Polyneuropathy |
2.8% |
| Renal Vasculitis |
2.8% |
| Restlessness |
2.8% |
| Tracheal Obstruction |
2.8% |
| Cholestasis |
1.4% |
| Drug Dependence |
1.4% |
| Fatigue |
1.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
14.9% |
| Schizophrenia |
13.8% |
| Product Used For Unknown Indication |
11.5% |
| Psychotic Disorder |
9.2% |
| Bipolar Disorder |
5.7% |
| Parenteral Nutrition |
5.7% |
| Schizoaffective Disorder |
5.7% |
| Cancer Pain |
4.6% |
| Tongue Neoplasm Malignant Stage Unspecified |
4.6% |
| Type 2 Diabetes Mellitus |
4.6% |
| Agitation |
2.3% |
| Body Temperature Increased |
2.3% |
| Depression |
2.3% |
| Hypertension |
2.3% |
| Multiple Sclerosis |
2.3% |
| Pneumonia |
2.3% |
| Sleep Disorder |
2.3% |
| Asthma |
1.1% |
| Convulsion |
1.1% |
| Gastritis Prophylaxis |
1.1% |
|
| Ileus Paralytic |
10.5% |
| Somnolence |
10.5% |
| Parkinsonism |
7.9% |
| Suicide Attempt |
7.9% |
| Blood Iron Decreased |
5.3% |
| Drowning |
5.3% |
| Glutamate Dehydrogenase Increased |
5.3% |
| Hepatitis |
5.3% |
| Loss Of Consciousness |
5.3% |
| Prescribed Overdose |
5.3% |
| Pyrexia |
5.3% |
| Renal Failure |
5.3% |
| Accidental Overdose |
2.6% |
| Anxiety |
2.6% |
| Cerebrovascular Accident |
2.6% |
| Completed Suicide |
2.6% |
| Death |
2.6% |
| Dyspnoea |
2.6% |
| Hepatic Cirrhosis |
2.6% |
| Hypothermia |
2.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
30.5% |
| Psychotic Disorder |
20.3% |
| Restlessness |
20.3% |
| Dyspnoea |
6.8% |
| Hallucination |
6.8% |
| Anxiety |
3.4% |
| Schizophrenia |
3.4% |
| Sedation |
3.4% |
| Depression |
1.7% |
| Schizoaffective Disorder |
1.7% |
| Sleep Disorder |
1.7% |
|
| Vomiting |
40.0% |
| Coma |
13.3% |
| Cardiac Arrest |
6.7% |
| Drug Interaction |
6.7% |
| Drug Level Increased |
6.7% |
| Galactorrhoea |
6.7% |
| Multiple Drug Overdose |
6.7% |
| Tardive Dyskinesia |
6.7% |
| Urinary Retention |
6.7% |
|
